The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

My husband died aged 72 from prostate cancer. He used talcum powder daily for 50 years and I read recently that it was linked ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis ...

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Researchers from the Washington University School of Medicine looked at the health outcomes among more than two million people taking the popular weight-loss medications.

Medicare announced plans to negotiate lower prices for 15 costly drugs, including Ozempic, Wegovy, and Trelegy Ellipta, ...